Recombinant CD80 (Galiximab Biosimilar) anticorps
Reactivité: Humain
BR, ELISA, FACS, IHC, IP, WB
Hôte: Lapin
Monoclonal
IDEC-114
unconjugated
Recombinant Antibody
1 image
-
- Antigène Tous les produits CD80 (Galiximab Biosimilar)
- CD80 (Galiximab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp CD80 (Galiximab Biosimilar) est non-conjugé
- Application
- Blocking Reagent (BR), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB)
- Attributs du produit
-
Original Species of Ab: Human
Original Format of Ab: IgG1
- Purification
- Purified antibody.
- Immunogène
- Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013)
- Clone
- IDEC-114
- Isotype
- IgG lambda
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Antigène
- CD80 (Galiximab Biosimilar)
- Abstract
- CD80 (Galiximab Biosimilar) Produits
- Synonymes
- anticorps B7, anticorps B7-1, anticorps B7.1, anticorps BB1, anticorps CD28LG, anticorps CD28LG1, anticorps LAB7, anticorps CD80 molecule, anticorps CD80
- Classe de substances
- Biosimilar
- Sujet
- B7-1, T-lymphocyte activation antigen CD80, Activation B7-1 antigen, BB1, CTLA-4 counter-receptor B7.1, B7
- UniProt
- P33681
-
Vous êtes ici:
